missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Marke:  R&D Systems™ 294-HGN-025

521.80 EUR gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.


 Weitere Artikel aus diesem Sortiment

Artikelnummer. 18127190

  • 664.00 € / 25 Mikrogramm

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

Entdecken Sie weitere Sonderangebote
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

  • Source: Mouse myeloma cell line, NS0-derived, Gln32-Ser728
  • Purity: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
  • Molecular Weight: alpha chain: 53.7 kDabeta chain: 26 kDa
  • Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
  • Entrez Gene ID: 3082
  • Regulatory Status: RUO

The Recombinant Human HGF (NS0-expressed) Protein is derived from NS0. The Recombinant Human HGF (NS0-expressed) Protein has been validated for the following applications: Bioactivity.
Spezifikation

Spezifikation

P14210.2
3082
HGF
Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile)
Disulfide-linked heterodimer
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
Predicted MW: alpha chain: 53.7kDa beta chain: 26kDa Observed MW: 65-75kDa, non-reducing conditions 60-65kDa and 30-40kDa, reducing conditions
25 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A
Recombinant
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote